- $8.33bn
- $11.27bn
- ARS2.53tn
- 57
- 35
- 77
- 57
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 435,820 | 678,595 | 669,186 | 1,271,330 | 2,526,466 |
Cost of Revenue | |||||
Gross Profit | 76,250 | 102,987 | 42,974 | 243,150 | 644,755 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 392,040 | 699,607 | 727,583 | 1,213,160 | 2,228,850 |
Operating Profit | 43,780 | -21,012 | -58,397 | 58,170 | 297,616 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 90,144 | -7,010 | -56,428 | 63,601 | 399,176 |
Provision for Income Taxes | |||||
Net Income After Taxes | 38,606 | -28,775 | -71,017 | -808 | 290,264 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 38,613 | -34,071 | -69,649 | 257 | 289,057 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 38,613 | -34,071 | -69,649 | 257 | 289,057 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 84.8 | -1.94 | -180 | 67.3 | 717 |
Dividends per Share |